Report top line data from the Phase 2 cystic fibrosis clinical trial program for ELX-02
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 13 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- November 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“We expect to report top line data from our proof of concept Phase 2 program in the first half of 2021, which is contingent on no further disruptions due to COVID-19.”
What we found
Evidence strength A What the grades mean
The company announced in July 2021 that the data readout was expected in the fourth quarter of 2021, and subsequently reported the results in November 2021, missing the first-half 2021 deadline.
-
A Eloxx Pharmaceuticals, Inc. 8-K filed 2021-07-06
“Data Readout for First Four Treatment Arms Expected in the Fourth Quarter of 2021” ✓ confirmed on the page
-
A Eloxx Pharmaceuticals, Inc. 10-K filed 2022-03-30
“In November 2021 we announced positive topline results from the monotherapy arms of this Phase 2 clinical trial” ✓ confirmed on the page
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Phase 2 cystic fibrosis clinical trial top line data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: contingent on no further disruptions due to COVID-19
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Not met”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Eloxx Pharmaceuticals, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ELOX-021988 · Corrections policy